The relatively new drug, denosumab, has proven itself very effective for men on a hormone blockade (ADT). In a recently completed 3-year, randomized, double-blind study at the Massachusetts General Hospital Cancer Center, Boston, Massachusetts, denosumab significantly increased bone mineral density and decreased new vertebral fractures in men receiving ADT for the treatment of advanced prostate [...]
There is a provenge clinical trial which is currently recruiting participants. Remember, as with all trials, you must fit all of the criteria to participate. This trial does not use a placebo, you are guaranteed to receive the treatment if you are approved to participate. The trial sites are: * Park Ridge, Illinois * Greenbelt, [...]
Inside all of us is fear Inside all of us is hope Inside all of us is the ability to use our hope to conquer our fear Joel T Nowak MA, MSW
At the ASCO Annual meeting in Orlando Florida, Cougar Biotechnology, Inc. announced perliminary results from their ongoing Phase II clinical trials of their much discussed investigational drug abiraterone acetate (CB7630). The company released some preliminary encouraging data in three separate poster presentations. First, I want to tell you what abiraterone acetate is. In scientific jargon [...]
I compiled a list of trials that are activily recruiting men with hormone refractory prostate cancer (HRPC) who have also failed chemotherapy (taxotere). Being at this point in the disease process is by far the scariest time. We face the reality that there are no more approved treatments available to control the cancer. Clinical trials [...]